Latest Blog: 1st April 2019

Evolving investments in gene technology

Genetic science and the creation of large genomic databases have opened up the possibilities for personalised medicine as never before. Amadeus has been investing in this space since the early days, when in 2001 we backed Solexa (now Illumina), the market leader in genetic testing equipment. Solexa’s low-cost technology was fundamental in enabling the development […]

Read in full